Back

Pomerantz investigates HCA Healthcare after 6.95% stock drop

Verifying
  • Pomerantz LLP is investigating HCA Healthcare and certain officers or directors on investors' behalf.
  • HCA shares fell $27.14, or 6.95%, closing at $363.60 on July 14, 2026.
  • HCA cited an unfavorable payer mix and approximately $400 million in quarterly revenue impact.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Pomerantz investigates HCA Healthcare after 6.95% stock drop - CoinPost Terminal